See II.2.4
The object of the contract consists in the acquisition of proprietary pharmaceutical products based on NITISINONE (ATC code A16AX04)
Duration: 2 year + 1 year + 1 year
Get our periodical newsletter about how sell more to the public sector and how to make the most of Tenderlake.